67 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd.
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
.
Section 7. Reimbursement of Underwriters’ Expenses. If this Agreement is terminated by the Representatives pursuant to Section 6, Section 11
8-K
EX-99.1
vpuw5ysa 0qh7
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
gnfta5r gie3
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
xswwa
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am